<p>Adjusted additionally for age, region of origin, delayed entry into care (≥3 mo between HIV diagnosis and first clinic visit), and HIV-exposure group. Late presentation: presenting for care with a CD4 count below 350/mm<sup>3</sup> or presenting with an AIDS defining event regardless of the CD4 count, in the 6 mo following presentation. Advanced disease: presenting for care with a CD4 count below 200/mm<sup>3</sup>or presenting with an AIDS defining event, regardless of CD4 cell count, in the 6 mo following presentation.</p>a<p>Figures are <i>n</i> (%) of clinical events (AIDS/deaths) in late presenters or late presenters with advanced disease.</p
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set ...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
<p>(A) Southern Europe. (B) Central Europe. (C) Northern Europe. (D) Eastern Europe. LP, diagnosed w...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Introduction. Most common causes of death in HIV patients in high income countries are related to la...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
Background: Late diagnosis represents a major challenge in the control of HIV epidemics. The rate of...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
Objectives In 2011, a consensus was reached defining “late presenters” (LPs) as individuals presenti...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set ...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
<p>(A) Southern Europe. (B) Central Europe. (C) Northern Europe. (D) Eastern Europe. LP, diagnosed w...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Introduction. Most common causes of death in HIV patients in high income countries are related to la...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
Background: Late diagnosis represents a major challenge in the control of HIV epidemics. The rate of...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
Objectives In 2011, a consensus was reached defining “late presenters” (LPs) as individuals presenti...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set ...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...